Dynavax Technologies Corp. Live Stock Price Today, Share Analysis and Chart

Name: Dynavax Technologies Corp.: Is Infosys Ltd. worth buying?
Item: Dynavax Technologies Corp.
Rating: 2.429597375
Author: Trendlyne DVM scores

Expensive Performer

about

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for...

11.06 -0.10 (-0.90%)

1.3M

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

High Financial Strength

55.6 / 100

Expensive Valuation

26.7 / 100

Technically Neutral

56.6 / 100

Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 106%

5 analysts

Dynavax Technologies Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dynavax Technologies Corp. Live Stock Price Today, Share Analysis and Chart

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for...

SWOT Analysis

Dynavax Technologies Corp Live Price Chart